|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.99 USD | -3.66% |
|
-5.53% | +626.91% |
| 04-30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
| 04-30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Sema4 Holdings Corp. reiterating earnings guidance for the year 2022. The company expects fiscal year 2022 total revenue to be in the range of $215 million to $225 million.
Fiscal year 2022 resulted test volume growth is expected to exceed 20% when compared to resulted volume for the full year of 2021 (excluding COVID-19 tests). The 2022 revenue, volume, and adjusted gross margin guidance excludes any contribution from the company's pending acquisition of GeneDx.
| 1st Jan change | Capi. | |
|---|---|---|
| +626.91% | 543M | |
| -20.85% | 8.01B | |
| +67.01% | 4.3B | |
| +0.32% | 2.55B | |
| -8.93% | 2.46B | |
| -38.69% | 2.44B | |
| -10.75% | 1.89B | |
| -19.84% | 1.59B | |
| -40.24% | 1.21B | |
| +16.56% | 1.17B |
GENEDX HOLDINGS CORP. 
